Report Detail
Global and United States Renal Cell Carcinoma Therapy Devices Market Report & Forecast 2022-2028
- RnM4420655 |
- 06 April, 2022 |
- Global |
- 99 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid tumors renders RCC incurable by surgical resection and consequently more difficult to treat. New molecular-targeted therapies have played a pivotal role in RCC treatment.
Market Analysis and Insights: Global and United States Renal Cell Carcinoma Therapy Devices Market
This report focuses on global and United States Renal Cell Carcinoma Therapy Devices market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Renal Cell Carcinoma Therapy Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Directed Energy-based Therapy Devices accounting for % of the Renal Cell Carcinoma Therapy Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Renal Cell Carcinoma Therapy Devices market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Renal Cell Carcinoma Therapy Devices Scope and Market Size
Renal Cell Carcinoma Therapy Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Renal Cell Carcinoma Therapy Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Renal Cell Carcinoma Therapy Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Renal Cell Carcinoma Therapy Devices market is segmented into
Directed Energy-based Therapy Devices
Drug/Fluid Delivery and Infusion Therapy Devices
Segment by Application, the Renal Cell Carcinoma Therapy Devices market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Renal Cell Carcinoma Therapy Devices Market Share Analysis
Renal Cell Carcinoma Therapy Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Renal Cell Carcinoma Therapy Devices business, the date to enter into the Renal Cell Carcinoma Therapy Devices market, Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
AngioDynamics, Inc.
Boston Scientific Corporation (Galil Medical, Inc.)
IceCure Medical
HealthTronics, Inc.
HistoSonics, Inc.
Integra LifeSciences Holdings Corporation
Medtronic plc
Monteris Medical, Inc.
Novocure GmbH
Varian Medical Systems, Inc.
Table of Contents
1 Study Coverage
- 1.1 Renal Cell Carcinoma Therapy Devices Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global Renal Cell Carcinoma Therapy Devices Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Renal Cell Carcinoma Therapy Devices Market Size for the Year 2017-2028
- 1.2.2 Global Renal Cell Carcinoma Therapy Devices Market Size for the Year 2017-2028
- 1.3 Renal Cell Carcinoma Therapy Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States Renal Cell Carcinoma Therapy Devices in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Renal Cell Carcinoma Therapy Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 Renal Cell Carcinoma Therapy Devices Market Dynamics
- 1.4.1 Renal Cell Carcinoma Therapy Devices Industry Trends
- 1.4.2 Renal Cell Carcinoma Therapy Devices Market Drivers
- 1.4.3 Renal Cell Carcinoma Therapy Devices Market Challenges
- 1.4.4 Renal Cell Carcinoma Therapy Devices Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 Renal Cell Carcinoma Therapy Devices by Type
- 2.1 Renal Cell Carcinoma Therapy Devices Market Segment by Type
- 2.1.1 Directed Energy-based Therapy Devices
- 2.1.2 Drug/Fluid Delivery and Infusion Therapy Devices
- 2.2 Global Renal Cell Carcinoma Therapy Devices Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Renal Cell Carcinoma Therapy Devices Market Size by Type (2017-2028)
- 2.4 United States Renal Cell Carcinoma Therapy Devices Market Size by Type (2017, 2022 & 2028)
- 2.5 United States Renal Cell Carcinoma Therapy Devices Market Size by Type (2017-2028)
3 Renal Cell Carcinoma Therapy Devices by Application
- 3.1 Renal Cell Carcinoma Therapy Devices Market Segment by Application
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global Renal Cell Carcinoma Therapy Devices Market Size by Application (2017, 2022 & 2028)
- 3.3 Global Renal Cell Carcinoma Therapy Devices Market Size by Application (2017-2028)
- 3.4 United States Renal Cell Carcinoma Therapy Devices Market Size by Application (2017, 2022 & 2028)
- 3.5 United States Renal Cell Carcinoma Therapy Devices Market Size by Application (2017-2028)
4 Global Renal Cell Carcinoma Therapy Devices Competitor Landscape by Company
- 4.1 Global Renal Cell Carcinoma Therapy Devices Market Size by Company
- 4.1.1 Top Global Renal Cell Carcinoma Therapy Devices Companies Ranked by Revenue (2021)
- 4.1.2 Global Renal Cell Carcinoma Therapy Devices Revenue by Player (2017-2022)
- 4.2 Global Renal Cell Carcinoma Therapy Devices Concentration Ratio (CR)
- 4.2.1 Renal Cell Carcinoma Therapy Devices Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Renal Cell Carcinoma Therapy Devices in 2021
- 4.2.3 Global Renal Cell Carcinoma Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Renal Cell Carcinoma Therapy Devices Headquarters, Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global Renal Cell Carcinoma Therapy Devices Headquarters and Area Served
- 4.3.2 Global Renal Cell Carcinoma Therapy Devices Companies Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into Renal Cell Carcinoma Therapy Devices Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States Renal Cell Carcinoma Therapy Devices Market Size by Company
- 4.5.1 Top Renal Cell Carcinoma Therapy Devices Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Renal Cell Carcinoma Therapy Devices Revenue by Players (2020, 2021 & 2022)
5 Global Renal Cell Carcinoma Therapy Devices Market Size by Region
- 5.1 Global Renal Cell Carcinoma Therapy Devices Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Renal Cell Carcinoma Therapy Devices Market Size by Region (2017-2028)
- 5.2.1 Global Renal Cell Carcinoma Therapy Devices Market Size by Region: 2017-2022
- 5.2.2 Global Renal Cell Carcinoma Therapy Devices Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Renal Cell Carcinoma Therapy Devices Market Size YoY Growth 2017-2028
- 6.1.2 North America Renal Cell Carcinoma Therapy Devices Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Renal Cell Carcinoma Therapy Devices Market Size YoY Growth 2017-2028
- 6.3.2 Europe Renal Cell Carcinoma Therapy Devices Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Renal Cell Carcinoma Therapy Devices Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Renal Cell Carcinoma Therapy Devices Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Renal Cell Carcinoma Therapy Devices Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Renal Cell Carcinoma Therapy Devices Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 AngioDynamics, Inc.
- 7.1.1 AngioDynamics, Inc. Company Details
- 7.1.2 AngioDynamics, Inc. Business Overview
- 7.1.3 AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Introduction
- 7.1.4 AngioDynamics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.1.5 AngioDynamics, Inc. Recent Development
- 7.2 Boston Scientific Corporation (Galil Medical, Inc.)
- 7.2.1 Boston Scientific Corporation (Galil Medical, Inc.) Company Details
- 7.2.2 Boston Scientific Corporation (Galil Medical, Inc.) Business Overview
- 7.2.3 Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Introduction
- 7.2.4 Boston Scientific Corporation (Galil Medical, Inc.) Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.2.5 Boston Scientific Corporation (Galil Medical, Inc.) Recent Development
- 7.3 IceCure Medical
- 7.3.1 IceCure Medical Company Details
- 7.3.2 IceCure Medical Business Overview
- 7.3.3 IceCure Medical Renal Cell Carcinoma Therapy Devices Introduction
- 7.3.4 IceCure Medical Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.3.5 IceCure Medical Recent Development
- 7.4 HealthTronics, Inc.
- 7.4.1 HealthTronics, Inc. Company Details
- 7.4.2 HealthTronics, Inc. Business Overview
- 7.4.3 HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Introduction
- 7.4.4 HealthTronics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.4.5 HealthTronics, Inc. Recent Development
- 7.5 HistoSonics, Inc.
- 7.5.1 HistoSonics, Inc. Company Details
- 7.5.2 HistoSonics, Inc. Business Overview
- 7.5.3 HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Introduction
- 7.5.4 HistoSonics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.5.5 HistoSonics, Inc. Recent Development
- 7.6 Integra LifeSciences Holdings Corporation
- 7.6.1 Integra LifeSciences Holdings Corporation Company Details
- 7.6.2 Integra LifeSciences Holdings Corporation Business Overview
- 7.6.3 Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Introduction
- 7.6.4 Integra LifeSciences Holdings Corporation Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.6.5 Integra LifeSciences Holdings Corporation Recent Development
- 7.7 Medtronic plc
- 7.7.1 Medtronic plc Company Details
- 7.7.2 Medtronic plc Business Overview
- 7.7.3 Medtronic plc Renal Cell Carcinoma Therapy Devices Introduction
- 7.7.4 Medtronic plc Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.7.5 Medtronic plc Recent Development
- 7.8 Monteris Medical, Inc.
- 7.8.1 Monteris Medical, Inc. Company Details
- 7.8.2 Monteris Medical, Inc. Business Overview
- 7.8.3 Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Introduction
- 7.8.4 Monteris Medical, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.8.5 Monteris Medical, Inc. Recent Development
- 7.9 Novocure GmbH
- 7.9.1 Novocure GmbH Company Details
- 7.9.2 Novocure GmbH Business Overview
- 7.9.3 Novocure GmbH Renal Cell Carcinoma Therapy Devices Introduction
- 7.9.4 Novocure GmbH Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.9.5 Novocure GmbH Recent Development
- 7.10 Varian Medical Systems, Inc.
- 7.10.1 Varian Medical Systems, Inc. Company Details
- 7.10.2 Varian Medical Systems, Inc. Business Overview
- 7.10.3 Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Introduction
- 7.10.4 Varian Medical Systems, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2017-2022)
- 7.10.5 Varian Medical Systems, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Get latest Market Research Reports on Renal Cell Carcinoma Therapy Devices. Industry analysis & Market Report on Renal Cell Carcinoma Therapy Devices is a syndicated market report, published as Global and United States Renal Cell Carcinoma Therapy Devices Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Renal Cell Carcinoma Therapy Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
